101 related articles for article (PubMed ID: 8145232)
1. [D-TRP32]neuropeptide Y: a competitive antagonist of NPY in rat hypothalamus.
Balasubramaniam A; Sheriff S; Johnson ME; Prabhakaran M; Huang Y; Fischer JE; Chance WT
J Med Chem; 1994 Mar; 37(6):811-5. PubMed ID: 8145232
[TBL] [Abstract][Full Text] [Related]
2. Effects of neuropeptide Y (NPY) and [D-Trp32]NPY on monoamine and metabolite levels in dialysates from rat hypothalamus during feeding behavior.
Matos FF; Guss V; Korpinen C
Neuropeptides; 1996 Aug; 30(4):391-8. PubMed ID: 8914867
[TBL] [Abstract][Full Text] [Related]
3. Antagonistic properties of centrally truncated analogs of [D-Trp(32)]NPY.
Balasubramaniam A; Ujhelyi M; Borchers M; Huang Y; Zhai W; Zhou Y; Johnson M; Sheriff S; Fischer JE
J Med Chem; 1996 Mar; 39(5):1142-7. PubMed ID: 8676351
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y (18-36) is a competitive antagonist of neuropeptide Y in rat cardiac ventricular membranes.
Balasubramaniam A; Sheriff S
J Biol Chem; 1990 Sep; 265(25):14724-7. PubMed ID: 2168390
[TBL] [Abstract][Full Text] [Related]
5. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
6. Anorexic action of a new potential neuropeptide Y antagonist [D-Tyr27,36, D-Thr32]-NPY (27-36) infused into the hypothalamus of the rat.
Myers RD; Wooten MH; Ames CD; Nyce JW
Brain Res Bull; 1995; 37(3):237-45. PubMed ID: 7627566
[TBL] [Abstract][Full Text] [Related]
7. WRYamide, a NPY-based tripeptide that antagonizes feeding in rats.
Chance WT; Tao Z; Sheriff S; Balasubramaniam A
Brain Res; 1998 Aug; 803(1-2):39-43. PubMed ID: 9729264
[TBL] [Abstract][Full Text] [Related]
8. Refractory hypothalamic adenylate cyclase in anorectic tumor-bearing rats: implications for NPY-induced feeding.
Chance WT; Balasubramaniam A; Borchers M; Fischer JE
Brain Res; 1995 Sep; 691(1-2):180-4. PubMed ID: 8590051
[TBL] [Abstract][Full Text] [Related]
9. N-alpha-biotinylated-neuropeptide Y analogs: syntheses, cardiovascular properties, and application to cardiac NPY receptor visualization.
Balasubramaniam A; Sheriff S; Ferguson DG; Stein M; Rigel DF
Peptides; 1990; 11(6):1151-6. PubMed ID: 1965029
[TBL] [Abstract][Full Text] [Related]
10. Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors.
Jain MR; Pu S; Kalra PS; Kalra SP
Endocrinology; 1999 Nov; 140(11):5171-7. PubMed ID: 10537146
[TBL] [Abstract][Full Text] [Related]
11. Pertussis toxin inhibits neuropeptide Y-induced feeding in rats.
Chance WT; Sheriff S; Foley-Nelson T; Fischer JE; Balasubramaniam A
Peptides; 1989; 10(6):1283-6. PubMed ID: 2560178
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structure, and antagonistic properties of des-Asn29[D-Trp28,32]NPY(27-36).
Balasubramaniam A; Zhai W; Tao Z; Huang Y; Fischer JE; Eden P; Taylor JE; Kar L; Samarasinghe SD; Johnson ME
Peptides; 1996; 17(7):1113-8. PubMed ID: 8959744
[TBL] [Abstract][Full Text] [Related]
13. Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake.
Kanatani A; Ishihara A; Asahi S; Tanaka T; Ozaki S; Ihara M
Endocrinology; 1996 Aug; 137(8):3177-82. PubMed ID: 8754736
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells.
Morgan DG; Kulkarni RN; Hurley JD; Wang ZL; Wang RM; Ghatei MA; Karlsen AE; Bloom SR; Smith DM
Diabetologia; 1998 Dec; 41(12):1482-91. PubMed ID: 9867216
[TBL] [Abstract][Full Text] [Related]
15. The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
Kanatani A; Kanno T; Ishihara A; Hata M; Sakuraba A; Tanaka T; Tsuchiya Y; Mase T; Fukuroda T; Fukami T; Ihara M
Biochem Biophys Res Commun; 1999 Dec; 266(1):88-91. PubMed ID: 10581170
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive effects of neuropeptide Y and related peptides in mice.
Broqua P; Wettstein JG; Rocher MN; Gauthier-Martin B; Riviere PJ; Junien JL; Dahl SG
Brain Res; 1996 Jun; 724(1):25-32. PubMed ID: 8816252
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and hypertensive activity of neuropeptide Y fragments and analogues with modified N- or C-termini or D-substitutions.
Boublik JH; Scott NA; Brown MR; Rivier JE
J Med Chem; 1989 Mar; 32(3):597-601. PubMed ID: 2918505
[TBL] [Abstract][Full Text] [Related]
18. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin.
Xu B; Dube MG; Kalra PS; Farmerie WG; Kaibara A; Moldawer LL; Martin D; Kalra SP
Endocrinology; 1998 Feb; 139(2):466-73. PubMed ID: 9449612
[TBL] [Abstract][Full Text] [Related]
19. Blockade of natural and neuropeptide Y-induced carbohydrate feeding by a receptor antagonist PYX-2.
Leibowitz SF; Xuereb M; Kim T
Neuroreport; 1992 Nov; 3(11):1023-6. PubMed ID: 1482761
[TBL] [Abstract][Full Text] [Related]
20. Characterization of functional neuropeptide Y receptors in a human neuroblastoma cell line.
Gordon EA; Kohout TA; Fishman PH
J Neurochem; 1990 Aug; 55(2):506-13. PubMed ID: 2164571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
